TCGX

Venture Capital

Science-driven investment firm dedicated to advancing disruptive medicines in biotech.

Palo Alto, United States · 15+ investments · 23 portfolio companies

Seed

Early Stage

Late Stage

Biotech

Healthcare

Headquarters: Palo Alto, United States
Founded: 2021
Website: tcgcrossover.com
AUM: $5.1B

Portfolio Companies: 23
Total Investments: 15
Last Investment: Jun 2026
Geographic Focus: United States, Europe, China

Investment Thesis

Invests in visionary entrepreneurs leveraging scientific breakthroughs to develop transformative medicines improving human health.

TCGX is a Venture Capital firm based in Palo Alto, United States. It has made 15 investments in Biotech and Healthcare, including Entrada Therapeutics, Korsana and Candid Therapeutics.

Portfolio23

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.